Additionally, gene expression studies examining reticulon 3 (RTN3), GPX4, and catalase (CAT) in CAD patients have identified novel molecular markers, enhancing our understanding of ferroptosis in CAD development (34). This evidence concerns the gene GPX4 and coronary artery disorder.